← All organizations

Forty Seven, Inc.

For profitWebsite ↗

Also known as: Forty Seven Inc | Forty Seven, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 30, 2020

Acquired by Gilead Sciences on Mar 2, 2020

Timeline

2010s

Jun 1, 2015
Forty Seven, Inc.— Founded

2020s

Mar 2, 2020
Gilead Sciences— Acquired By

Drugs by trial phase (12 distinct, 8 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (9 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

avelumab

Indications

Studied for

Recent trials (14)

NCT04313881Lead sponsorPhase 3Jun 30, 2020
NCT04313881Study directorPhase 3Jun 30, 2020
NCT03869190CollaboratorPhase 1/Phase 2Apr 30, 2019
NCT03558139Lead sponsorPhase 1May 24, 2018
NCT03248479Lead sponsorPhase 1Sep 12, 2017
NCT03248479Study chairPhase 1Sep 12, 2017
NCT02953509Study chairPhase 1/Phase 2Nov 1, 2016
NCT02953509Lead sponsorPhase 1/Phase 2Nov 1, 2016
NCT02953782Study chairPhase 1/Phase 2Nov 1, 2016
NCT02953782Lead sponsorPhase 1/Phase 2Nov 1, 2016
NCT02678338Study directorPhase 1Nov 1, 2015
NCT02678338Lead sponsorPhase 1Nov 1, 2015
NCT02216409Study chairPhase 1Aug 1, 2014
NCT02216409Lead sponsorPhase 1Aug 1, 2014

Details

Founded: Palo Alto, CA, US Jun 1, 2015
Last known activity: Jun 30, 2020